Brian A. Stemme
Directeur/Membre du Conseil chez Butler University
Profil
Brian A.
Stemme is currently a Director at Scioto Biosciences, Inc. and a Trustee at Butler University.
He has formerly worked as a Director at Muroplex Therapeutics, Inc., AgeneBio, Inc., and Algaeon, Inc. He was also a Principal at Eli Lilly & Co. and Arthur Andersen LLP.
Mr. Stemme received his undergraduate degree from Butler University in 1991.
Postes actifs de Brian A. Stemme
Sociétés | Poste | Début |
---|---|---|
Butler University | Directeur/Membre du Conseil | 28/07/2009 |
Scioto Biosciences, Inc.
Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
Anciens postes connus de Brian A. Stemme
Sociétés | Poste | Fin |
---|---|---|
Algaeon, Inc.
Algaeon, Inc. Agricultural Commodities/MillingProcess Industries Algaeon, Inc. operates as a biotech company that produces Astaxanthin. Its technology used to produce nutraceuticals, including antioxidants, essential oils, and therapeutics; animal feed additives; and biofuels, such as replacement gasoline, diesel, jet turbine, and aviation gas fuels. The company was founded by John A. Kassebaum and William R. Kassebaum in 2011 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Muroplex Therapeutics, Inc.
Muroplex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Muroplex Therapeutics, Inc. engages in the manufacture of pharmaceutical preparations. It focuses on directing immunity in humans and animals by rational manipulation of natural molecular signals that drive immune response. The company was founded by Larry C. Blaszczak and David E. Seitz on September 27, 2005 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
Formation de Brian A. Stemme
Butler University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 5 |
---|---|
Muroplex Therapeutics, Inc.
Muroplex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Muroplex Therapeutics, Inc. engages in the manufacture of pharmaceutical preparations. It focuses on directing immunity in humans and animals by rational manipulation of natural molecular signals that drive immune response. The company was founded by Larry C. Blaszczak and David E. Seitz on September 27, 2005 and is headquartered in Indianapolis, IN. | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
Algaeon, Inc.
Algaeon, Inc. Agricultural Commodities/MillingProcess Industries Algaeon, Inc. operates as a biotech company that produces Astaxanthin. Its technology used to produce nutraceuticals, including antioxidants, essential oils, and therapeutics; animal feed additives; and biofuels, such as replacement gasoline, diesel, jet turbine, and aviation gas fuels. The company was founded by John A. Kassebaum and William R. Kassebaum in 2011 and is headquartered in Indianapolis, IN. | Process Industries |
Scioto Biosciences, Inc.
Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Health Technology |